NASDAQ:SUPN

Supernus Pharmaceuticals Stock Insider Trading

Healthcare > Drug Manufacturers - Specialty & Generic

Buy SUPN

*Your capital is at risk

$44.04

-0.0350 (-0.0794%)

At Close: Jun 03, 2026

Supernus Pharmaceuticals Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -46.55. In total, the insiders bought 563.66K and sold 247.69K SUPN shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	-46.55
● Buy	563.66K shares
● Sell	247.69K shares
56% Buy Activity Moderate Negative Correlation
Buy Signal Low Confidence Mar 02, 2026 Analysis Breakdown: Signal is highly questionable due to a strongly contradictory negative Insider Power Score of -46.55. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Mar 18, 2026 Buy	Common Stock M-Exempt	Bhatt Padmanabh P. Sr. Vp Of Ip, Cso	Officer	7 250 Value: $285.7K
Mar 18, 2026 Sell	Common Stock S-Sale	Bhatt Padmanabh P. Sr. Vp Of Ip, Cso	Officer	6 838 Value: $338.8K
Mar 18, 2026 Buy	Employee Stock Option (Right to Buy) M-Exempt	Bhatt Padmanabh P. Sr. Vp Of Ip, Cso	Officer	7 250 Value: $285.7K
Mar 18, 2026 Sell	Common Stock S-Sale	Bhatt Padmanabh P. Sr. Vp Of Ip, Cso	Officer	412 Value: $20.8K
Mar 17, 2026 Buy	Common Stock M-Exempt	Bhatt Padmanabh P. Sr. Vp Of Ip, Cso	Officer	15 000 Value: $579.0K
Mar 17, 2026 Buy	Common Stock M-Exempt	Bhatt Padmanabh P. Sr. Vp Of Ip, Cso	Officer	12 250 Value: $450.2K
Mar 17, 2026 Buy	Common Stock M-Exempt	Bhatt Padmanabh P. Sr. Vp Of Ip, Cso	Officer	22 750 Value: $896.4K
Mar 17, 2026 Sell	Common Stock S-Sale	Bhatt Padmanabh P. Sr. Vp Of Ip, Cso	Officer	27 710 Value: $1.38M
Mar 17, 2026 Sell	Common Stock S-Sale	Bhatt Padmanabh P. Sr. Vp Of Ip, Cso	Officer	22 290 Value: $1.13M
Mar 17, 2026 Buy	Employee Stock Option (Right to Buy) M-Exempt	Bhatt Padmanabh P. Sr. Vp Of Ip, Cso	Officer	22 750 Value: $896.4K
Mar 17, 2026 Buy	Employee Stock Option (Right to Buy) M-Exempt	Bhatt Padmanabh P. Sr. Vp Of Ip, Cso	Officer	15 000 Value: $579.0K
Mar 17, 2026 Buy	Employee Stock Option (Right to Buy) M-Exempt	Bhatt Padmanabh P. Sr. Vp Of Ip, Cso	Officer	12 250 Value: $450.2K
Mar 16, 2026 Buy	Common Stock M-Exempt	Bhatt Padmanabh P. Sr. Vp Of Ip, Cso	Officer	18 000 Value: $579.6K
Mar 16, 2026 Buy	Common Stock M-Exempt	Bhatt Padmanabh P. Sr. Vp Of Ip, Cso	Officer	4 250 Value: $125.8K
Mar 16, 2026 Buy	Common Stock M-Exempt	Bhatt Padmanabh P. Sr. Vp Of Ip, Cso	Officer	22 750 Value: $836.1K
Mar 16, 2026 Sell	Common Stock S-Sale	Bhatt Padmanabh P. Sr. Vp Of Ip, Cso	Officer	34 114 Value: $1.71M
Mar 16, 2026 Buy	Employee Stock Option (Right to Buy) M-Exempt	Bhatt Padmanabh P. Sr. Vp Of Ip, Cso	Officer	22 750 Value: $836.1K
Mar 16, 2026 Buy	Employee Stock Option (Right to Buy) M-Exempt	Bhatt Padmanabh P. Sr. Vp Of Ip, Cso	Officer	18 000 Value: $579.6K
Mar 16, 2026 Buy	Employee Stock Option (Right to Buy) M-Exempt	Bhatt Padmanabh P. Sr. Vp Of Ip, Cso	Officer	4 250 Value: $125.8K
Mar 16, 2026 Buy	Employee Stock Option (Right to Buy) M-Exempt	Bhatt Padmanabh P. Sr. Vp Of Ip, Cso	Officer	5 000 Value: $139.7K
Mar 16, 2026 Sell	Common Stock S-Sale	Bhatt Padmanabh P. Sr. Vp Of Ip, Cso	Officer	15 886 Value: $802.1K
Mar 16, 2026 Buy	Common Stock M-Exempt	Bhatt Padmanabh P. Sr. Vp Of Ip, Cso	Officer	5 000 Value: $139.7K
Mar 13, 2026 Sell	Common Stock S-Sale	Khattar Jack A. President, CEO	CEO / President	24 138 Value: $1.21M
Mar 13, 2026 Sell	Common Stock S-Sale	Khattar Jack A. President, CEO	CEO / President	10 742 Value: $547.8K
Mar 13, 2026 Sell	Common Stock J-Other	Khattar Jack A. President, CEO	CEO / President	12 500 Value: $0

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT SUPERNUS PHARMACEUTICALS

Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prophylaxis of migraine headache; and Oxtellar XR, an extended release oxcarbazepine for the monotherapy tr...

Read Full Profile Here